BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1348053)

  • 1. Binding parameters of phenytoin during monotherapy and polytherapy.
    Pospísil J; Perlík F
    Int J Clin Pharmacol Ther Toxicol; 1992 Jan; 30(1):24-8. PubMed ID: 1348053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
    Irshaid YM; Hamdi AA; Al Homrany M
    Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum protein binding of antiepileptic drugs in Sri Lankans.
    Karunanayake EH; Joice PD; Peiris JB; Meijer JW; Meinardi H
    Ceylon Med J; 1990 Mar; 35(1):25-8. PubMed ID: 2361227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PB:PRM ratio in patients with epilepsy treated with primidone.
    Cornaggia CM; Altamura AC; Bianchi M; Canger R; Polana P; Pruneri C
    Int J Clin Pharmacol Res; 1983; 3(3):185-93. PubMed ID: 6679521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic ranges of anti-epileptic drugs in monotherapy of children].
    Armijo Simón JA; Herranz Fernández JL; Valiente Domingo R; Arteaga Manjón-Cabeza R
    An Esp Pediatr; 1991 Jan; 34(1):32-42. PubMed ID: 2018256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate.
    Della Paschoa OE; Voskuyl RA; Danhof M
    Br J Pharmacol; 1998 Dec; 125(7):1610-6. PubMed ID: 9884091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
    Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
    Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum trace elements, glutathione, copper/zinc superoxide dismutase, and lipid peroxidation in epileptic patients with phenytoin or carbamazepine monotherapy.
    Liu CS; Wu HM; Kao SH; Wei YH
    Clin Neuropharmacol; 1998; 21(1):62-4. PubMed ID: 9579288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.
    El Desoky E; Kandil MR; Afifi AH; Mostafa OA
    Pharmacol Res; 1999 Apr; 39(4):269-74. PubMed ID: 10208756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?
    Johno I; Kuzuya T; Suzuki K; Hasegawa M; Nakamura T; Kitazawa S; Aso K; Watanabe K
    Ther Drug Monit; 1988; 10(1):39-44. PubMed ID: 3376180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "An analysis of epileptic patients nonresponsive to drugs".
    Karande SC; Joshi MV; Kshirsagar NA; Shah PU
    J Assoc Physicians India; 1992 Jul; 40(7):445-7. PubMed ID: 1484024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment of epilepsy today.
    Benna P; Bergamasco B
    Funct Neurol; 1986; 1(4):487-93. PubMed ID: 2886407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of antiepileptic drugs on sleep patterns.
    Declerck AC; Wauquier A
    Epilepsy Res Suppl; 1991; 2():153-63. PubMed ID: 1684711
    [No Abstract]   [Full Text] [Related]  

  • 20. [Computerized stabilometry in the monitoring of antiepileptic therapy in children].
    Franzoni E; Crisanti AF; Arcuri S; Buccolieri M; Bergonzoni C
    Pediatr Med Chir; 1995; 17(5):407-9. PubMed ID: 8684994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.